Marc J. Claeys

Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries.

J. Jukema, T. Lüscher, P. Erne, 2016, European heart journal. Cardiovascular pharmacotherapy.

2023 ESC Guidelines for the management of acute coronary syndromes.

L. Fauchier, L. Neubeck, L. Räber, 2023, European heart journal. Acute cardiovascular care.

TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING CORONARY ARTERY BY-PASS SURGERY: RESULTS FROM THE PLATO TRIAL

C. Held, C. Cannon, K. Mahaffey, 2010 .

Guidelines on the Management of Valvular Heart disease (Version 2012)

E. Schwammenthal, G. Filippatos, J. Schwitter, 2013 .

Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries.

F. Van de Werf, P. van de Borne, M. Vrolix, 2016, Acta cardiologica.

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.